icon-folder.gif   Conference Reports for NATAP  
 
  16th International Workshop
on Clinical Pharmacology of HIV
and Hepatitis Therapy
May 26-28, 2015
Washington, DC
Back grey_arrow_rt.gif
 
 
 
Pharmacokinetics of Dasabuvir when Administered with
Ombitasvir, Paritaprevir and Ritonavir in Healthy Volunteers

 
 
  Reported by Jules Levin
16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy Washington D.C., May 26-28, 2015
 
Akshanth Polepally1, Matthew Kosloski1, Amit Khatri1, Rajeev Menon1, Sandeep Dutta1 1AbbVie Inc., Clinical Pharmacology and Pharmacometrics, North Chicago, IL, USA Presented at the 16th International Workshop on Clinical Pharmacology of HIV and Hepatitis Therapy, May 26 - 28, 2015, Washington, DC, USA
 
Clinical Pharm of HIV & Hepatitis Ombitasvir/Paritaprevir/Ritonavir + Dasabuvir: Drug Interactions with Antiretroviral Agents - (06/01/15)
 
Clinical Pharm of HIV & Hepatitis Assessment of Drug-Drug Interactions Between Daclatasvir and Darunavir/Ritonavir or Lopinavir/Ritonavir - (06/03/15)

Pharm1.gif

Pharm2.gif

Pharm3.gif

Pharm4.gif

Pharm5.gif

Pharm6.gif

Pharm7.gif

Pharm8.gif